The central carbon metabolism in cancer pathway (ecb05230, e.g., LDHB, HK2) controls cancer metabolic adaptations through aerobic glycolysis, elevated glutaminolysis, dysregulated tricarboxylic acid cycle and pentose phosphate pathways [92]. This evidence concerns the gene HK2 and cancer.